Cargando…

Genome-Wide Screening Identifies Gene AKR1C1 Critical for Resistance to Pirarubicin in Bladder Cancer

SIMPLE SUMMARY: Bladder cancer is one of the most common malignant tumors in the urinary system. Pirarubicin (THP) perfusion therapy is an important treatment method for non-muscle-invasive bladder cancer. However, an increasing number of cases of recurrence or progression of bladder cancer caused b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nie, Zhenyu, Gao, Yuanhui, Chen, Mei, Peng, Yanling, Guo, Na, Cao, Hui, Huang, Denggao, Gao, Xin, Zhang, Shufang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177075/ https://www.ncbi.nlm.nih.gov/pubmed/37173953 http://dx.doi.org/10.3390/cancers15092487

Ejemplares similares

Endoplasmic Reticulum Stress and Tumor Microenvironment in Bladder Cancer: The Missing Link
por: Nie, Zhenyu, et al.
Publicado: (2021)

RNA-Binding Proteins in Bladder Cancer
por: Gao, Yuanhui, et al.
Publicado: (2023)

Regulated Cell Death in Urinary Malignancies
por: Nie, Zhenyu, et al.
Publicado: (2021)

Scabertopin Derived from Elephantopus scaber L. Mediates Necroptosis by Inducing Reactive Oxygen Species Production in Bladder Cancer In Vitro
por: Gao, Yuanhui, et al.
Publicado: (2022)

Duality of the SVIL expression in bladder cancer and its correlation with immune infiltration
por: Nie, Zhenyu, et al.
Publicado: (2023)

Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges
por: Nie, Zhenyu, et al.
Publicado: (2022)

Development of a polyamine gene expression score for predicting prognosis and treatment response in clear cell renal cell carcinoma
por: Chen, Mei, et al.
Publicado: (2022)

Machine learning-based on cytotoxic T lymphocyte evasion gene develops a novel signature to predict prognosis and immunotherapy responses for kidney renal clear cell carcinoma patients
por: Chen, Mei, et al.
Publicado: (2023)

Rac3 Expression and its Clinicopathological Significance in Patients With Bladder Cancer
por: Chen, Mei, et al.
Publicado: (2021)

Knockdown of SLC35F2 Inhibits the Proliferation and Metastasis of Bladder Cancer Cells
por: Chen, Mei, et al.
Publicado: (2019)

A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients
por: Chen, Mei, et al.
Publicado: (2021)

In vitro and in vivo studies of pirarubicin-loaded SWNT for the treatment of bladder cancer
por: Chen, Gang, et al.
Publicado: (2012)

Application of pirarubicin photosensitizer fluorescence cystoscopy in early detection of bladder cancer
por: Jiang, Bo, et al.
Publicado: (2017)

m7G regulator-mediated molecular subtypes and tumor microenvironment in kidney renal clear cell carcinoma
por: Chen, Mei, et al.
Publicado: (2022)

Dual Inhibition of Pirarubicin-Induced AKT and ERK Activations by Phenformin Sensitively Suppresses Bladder Cancer Growth
por: Peng, Mei, et al.
Publicado: (2019)

Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma
por: Chen, Mei, et al.
Publicado: (2020)

Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases
por: Rižner, Tea Lanišnik
Publicado: (2012)

Efficacy of pirarubicin for nonmuscle invasive bladder cancer: A protocol of systematic review and meta-analysis
por: Chen, Da-Yin, et al.
Publicado: (2020)

Prognostic value of CLIC3 mRNA overexpression in bladder cancer
por: Chen, Mei, et al.
Publicado: (2020)

A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil, pirarubicin and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients
por: Wu, Lina, et al.
Publicado: (2015)

Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers
por: Laffin, Brian, et al.
Publicado: (2012)

Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma
por: Zhu, Pengfei, et al.
Publicado: (2021)

AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2021)

Roles of AKR1C3 in malignancy
por: Xiao, Xin-Zhu, et al.
Publicado: (2021)

Aldo–Keto Reductase AKR1C1–AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy
por: Zeng, Chen-Ming, et al.
Publicado: (2017)

AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma
por: Gao, Cheng, et al.
Publicado: (2023)

Pharmacology and antitumour effects of intraportal pirarubicin on experimental liver metastases.
por: Ramirez, L. H., et al.
Publicado: (1993)

Membrane Transport and Antitumor Activity of Pirarubicin, and Comparison with Those of Doxorubicin
por: Sugiyama, Tomomi, et al.
Publicado: (1999)

In-silico Investigations of quinine and quinidine as potential Inhibitors of AKR1B1 and AKR1B10: Functional and structural characterization
por: Ejaz, Syeda Abida, et al.
Publicado: (2022)

AKR1B10 in gastrointestinal diseases
por: Shen, Yi, et al.
Publicado: (2015)

Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line
por: Kljun, Jakob, et al.
Publicado: (2022)

Synthesis and therapeutic effect of styrene–maleic acid copolymer-conjugated pirarubicin
por: Tsukigawa, Kenji, et al.
Publicado: (2015)

Targeting the microRNA-21/AP1 axis by 5-fluorouracil and pirarubicin in human hepatocellular carcinoma
por: He, Xiaodong, et al.
Publicado: (2014)

Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma
por: Lewis, Michael J, et al.
Publicado: (2004)

Impact of low-intensity pulsed ultrasound on transcription and metabolite compositions in proliferation and functionalization of human adipose-derived mesenchymal stromal cells
por: Huang, Denggao, et al.
Publicado: (2020)

Modeling Single Nucleotide Polymorphisms in the Human AKR1C1 and AKR1C2 Genes: Implications for Functional and Genotyping Analyses
por: Arthur, Jonathan W., et al.
Publicado: (2010)

AKR1C2 and AKR1C3 expression in adipose tissue: Association with body fat distribution and regulatory variants
por: Ostinelli, Giada, et al.
Publicado: (2021)

Effect of Tumor Targeted-Anthracycline Nanomedicine, HPMA Copolymer-Conjugated Pirarubicin (P-THP) against Gynecological Malignancies
por: Yanazume, Shintaro, et al.
Publicado: (2022)

AKR1C1-3, notably AKR1C3, are distinct biomarkers for liver cancer diagnosis and prognosis: Database mining in malignancies
por: Zhao, Shou-Feng, et al.
Publicado: (2019)

Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling
por: Gao, Yunshu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m9r0uicr3ajckhr7ba5rer77r9